The Patent Finder

Targeted Molecular Diagnostics, LLC

Also on record
Records under this name other than patents Targeted Molecular Diagnostics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Targeted Molecular Diagnostics, LLC

PatentTitleStatus Expires Confidence
US 7,862,995Methods and Materials for Predicting Responsiveness to Treatment with Dual Tyrosine Kinase Inhibitor
Lapsed on the fee record
Ended Jan 4, 2019 · High confidence
Lapsed on the fee recordEnded Jan 4, 2019High confidence
US 8,709,738Methods for Predicting Cardiac Toxicity
Formerly held
Lapsed on the fee record
Ended Apr 29, 2018 · High confidence
Lapsed on the fee recordEnded Apr 29, 2018High confidence
US 8,623,604Methods for Predicting Responsiveness of a Cancer Cell to an ANTI-IGFR1 Antibody by Analysis of Mutations in PIK3CA
Formerly held
Lapsed on the fee record
Ended Jan 7, 2018 · High confidence
Lapsed on the fee recordEnded Jan 7, 2018High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited